Jade Ebbelaar

Jade Ebbelaar

Auto-generated profile, based on publicly available information

Jade Ebbelaar

Amsterdam UMC, Laboratory of Experimental Clinical Chemistry, Laboratory Specialized Diagnostics & Research, Department of Laboratory Medicine University of Amsterdam Amsterdam the Netherlands

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2025 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
Agustin Enciso-MartinezAgustin Enciso-Martinez
Agustin Enciso-Martinez
CLCaroline Løppke
Caroline Løppke
JKJoyce J. Koene
Joyce J. Koene
JEJade Ebbelaar
Jade Ebbelaar
MGMeike van der Geest
Meike van der Geest
PDPeter Ten Dijke
Peter Ten Dijke
Tumour‐derived extracellular vesicles (tdEVs) are widely studied for their contribution to tumour progression and metastasis. These studies are hampered by the lack of specific markers to identify the tdEVs. Here, we show that oncofoetal chondroitin sulphate, a malignancy‐associated glycosaminoglycan modification, is present on tdEVs and can be targeted by the malaria VAR2CSA protein or C9 antibody. Using a fluorescently labelled recombinant VAR2CSA protein, we identified EVs from cancer cells in vitro by super‐resolution fluorescence microscopy and flow cytometry, as well as in a proof‐of‐concept study using plasma samples from pancreatic adenocarcinoma patients. Thus, the binding of VAR2CSA offers a tool to identify tdEVs, and can be used to explore their function and biomarker potential in cancer.